1. Home
  2. BANL vs LGVN Comparison

BANL vs LGVN Comparison

Compare BANL & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

N/A

Current Price

$4.60

Market Cap

19.0M

Sector

Energy

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$2.53

Market Cap

21.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANL
LGVN
Founded
2015
2014
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
21.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
BANL
LGVN
Price
$4.60
$2.53
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
32.5K
★ 138.4K
Earning Date
08-18-2026
11-03-2026
Dividend Yield
★ 2.22%
N/A
EPS Growth
N/A
★ 50.76
EPS
★ N/A
N/A
Revenue
N/A
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.27
$0.48
52 Week High
$16.40
$7.60

Technical Indicators

Market Signals
Indicator
BANL
LGVN
Relative Strength Index (RSI) 33.93 40.54
Support Level $0.36 $0.61
Resistance Level $5.34 $7.45
Average True Range (ATR) 0.41 0.34
MACD -0.26 -0.36
Stochastic Oscillator 7.69 7.92

Price Performance

Historical Comparison
BANL
LGVN

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: